Latest News

Big multiple sclerosis breakthrough: Phase 1 trial safely resets patients' immune systems and reduces attack on myelin protein

A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to 75 percent. The therapy used billions of patients' own specially processed blood cells to create tolerance to myelin, the insulating layer that forms around nerves. In MS, the immune system attacks myelin. The approach left the normal immune system intact.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Pinpointing mutations in a relapsed children's cancer may lead to improved treatments

  • Infection with Wolbachia bacteria curbs fighting among fruit flies

  • Rapid response to kids' stroke symptoms may speed diagnosis

  • Commonly prescribed drugs affect decisions to harm oneself and others

  • Long-term memories are maintained by prion-like proteins

  • Do you really think you're a foodie?

  • Water to understand the brain

  • Can autism be measured in a sniff?

  • Intrusiveness of old emotional memories can be reduced by computer game play procedure

  • Computer learning system detects emotional context in text messages

  •